Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Oct 15;351(Pt 2):319–326.

Anti-(herpes simplex virus) activity of 4'-thio-2'-deoxyuridines: a biochemical investigation for viral and cellular target enzymes.

A Verri 1, F Focher 1, R J Duncombe 1, I Basnak 1, R T Walker 1, P L Coe 1, E de Clercq 1, G Andrei 1, R Snoeck 1, J Balzarini 1, S Spadari 1
PMCID: PMC1221366  PMID: 11023816

Abstract

The antiviral activity of several nucleoside analogues is often limited by their rapid degradation by pyrimidine nucleoside phosphorylases. In an attempt to avoid this degradation, several modified nucleosides have been synthesized. A series of 4'-thio-2'-deoxyuridines exhibits an anti-[herpes simplex virus (HSV)] activity significantly higher (20-600 times) than that shown by the corresponding 4'-oxy counterpart. We investigated the mode of action of these compounds and we found that: (i) several 4'-thio-2'-deoxyuridines are phosphorylated to the mono- and di-phosphates by HSV-1 thymidine kinase (TK) more efficiently than their corresponding 4'-oxy counterpart; (ii) both are inhibitors of cellular thymidylate synthase; (iii) 4'-thio-2'-deoxyuridines are resistant to phosphorolysis by human thymidine phosphorylase; (iv) both 4'-oxy- and 4'-thio-2'-deoxyuridines are phosphorylated to deoxyribonucleotide triphosphate in HSV-1-infected cells and are incorporated into viral DNA; (v) 4'-thio-2'-deoxyuridines are better inhibitors than their 4'-oxy counterparts of [(3)H]thymidine incorporation in HSV-1-infected cells; (vi) 4'-thio-2'-deoxyuridines are not recognized by HSV-1 and human uracil-DNA glycosylases. Our data suggest that 4'-thio-2'-deoxyuridines, resistant to pyrimidine phosphorylase, can be preferentially or selectively phosphorylated by viral TK in HSV-infected cells, where they are further converted into triphosphate by cellular nucleotide kinases. Once incorporated into viral DNA, they are better inhibitors of viral DNA synthesis than their corresponding 4'-oxy counterpart, either because they are not recognized, and thus not removed, by viral uracil-DNA glycosylase, or because they preferentially interfere with viral DNA polymerase.

Full Text

The Full Text of this article is available as a PDF (168.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argnani R., Focher F., Zucchini S., Verri A., Wright G. E., Spadari S., Manservigi R. Herpes simplex virus type 1 (HSV-1) uracil-DNA glycosylase: functional expression in Escherichia coli, biochemical characterization, and selective inhibition by 6-(p-n-octylanilino)uracil. Virology. 1995 Aug 1;211(1):307–311. doi: 10.1006/viro.1995.1406. [DOI] [PubMed] [Google Scholar]
  2. Balzarini J., Bohman C., De Clercq E. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J Biol Chem. 1993 Mar 25;268(9):6332–6337. [PubMed] [Google Scholar]
  3. Balzarini J., De Clercq E., Baumgartner H., Bodenteich M., Griengl H. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1. Mol Pharmacol. 1990 Mar;37(3):395–401. [PubMed] [Google Scholar]
  4. Balzarini J., De Clercq E. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells. Methods Find Exp Clin Pharmacol. 1989 Jun;11(6):379–389. [PubMed] [Google Scholar]
  5. Desgranges C., Razaka G., Rabaud M., Bricaud H., Balzarini J., De Clercq E. Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets. Biochem Pharmacol. 1983 Dec 1;32(23):3583–3590. doi: 10.1016/0006-2952(83)90307-6. [DOI] [PubMed] [Google Scholar]
  6. Desgranges C., Razaka G., Rabaud M., Picard P., Dupuch F., Bricaud H. The human blood platelet: a cellular model to study the degradation of thymidine and its inhibition. Biochem Pharmacol. 1982 Sep 1;31(17):2755–2759. doi: 10.1016/0006-2952(82)90129-0. [DOI] [PubMed] [Google Scholar]
  7. Dyson M. R., Coe P. L., Walker R. T. The synthesis and antiviral activity of some 4'-thio-2'-deoxy nucleoside analogues. J Med Chem. 1991 Sep;34(9):2782–2786. doi: 10.1021/jm00113a016. [DOI] [PubMed] [Google Scholar]
  8. Dyson M. R., Coe P. L., Walker R. T. The synthesis and antiviral activity of some 4'-thio-2'-deoxynucleoside analogues. Nucleic Acids Symp Ser. 1991;(24):1–4. [PubMed] [Google Scholar]
  9. Focher F., Hildebrand C., Freese S., Ciarrocchi G., Noonan T., Sangalli S., Brown N., Spadari S., Wright G. N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase. J Med Chem. 1988 Aug;31(8):1496–1500. doi: 10.1021/jm00403a004. [DOI] [PubMed] [Google Scholar]
  10. Focher F., Ubiali D., Pregnolato M., Zhi C., Gambino J., Wright G. E., Spadari S. Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis. J Med Chem. 2000 Jun 29;43(13):2601–2607. doi: 10.1021/jm000037u. [DOI] [PubMed] [Google Scholar]
  11. Focher F., Verri A., Spadari S., Manservigi R., Gambino J., Wright G. E. Herpes simplex virus type 1 uracil-DNA glycosylase: isolation and selective inhibition by novel uracil derivatives. Biochem J. 1993 Jun 15;292(Pt 3):883–889. doi: 10.1042/bj2920883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Herdewijn P., De Clercq E., Balzarini J., Vanderhaeghe H. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines. J Med Chem. 1985 May;28(5):550–555. doi: 10.1021/jm50001a003. [DOI] [PubMed] [Google Scholar]
  13. Miura G. A., Gordon R. K., Montgomery J. A., Chiang P. K. 4'-Thioadenosine as a novel inhibitor of S-adenosylhomocysteine hydrolase and an inducer for the differentiation of HL-60 human leukemia cells. Adv Exp Med Biol. 1986;195(Pt B):667–672. doi: 10.1007/978-1-4684-1248-2_104. [DOI] [PubMed] [Google Scholar]
  14. Moghaddam A., Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry. 1992 Dec 8;31(48):12141–12146. doi: 10.1021/bi00163a024. [DOI] [PubMed] [Google Scholar]
  15. Montgomery J. A. Studies on the biologic activity of purine and pyrimidine analogs. Med Res Rev. 1982 Jul-Sep;2(3):271–308. doi: 10.1002/med.2610020304. [DOI] [PubMed] [Google Scholar]
  16. Otterlei M., Warbrick E., Nagelhus T. A., Haug T., Slupphaug G., Akbari M., Aas P. A., Steinsbekk K., Bakke O., Krokan H. E. Post-replicative base excision repair in replication foci. EMBO J. 1999 Jul 1;18(13):3834–3844. doi: 10.1093/emboj/18.13.3834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rahim S. G., Trivedi N., Bogunovic-Batchelor M. V., Hardy G. W., Mills G., Selway J. W., Snowden W., Littler E., Coe P. L., Basnak I. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides. J Med Chem. 1996 Feb 2;39(3):789–795. doi: 10.1021/jm950029r. [DOI] [PubMed] [Google Scholar]
  18. Spadari S., Ciarrocchi G., Focher F., Verri A., Maga G., Arcamone F., Iafrate E., Manzini S., Garbesi A., Tondelli L. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies. Mol Pharmacol. 1995 Jun;47(6):1231–1238. [PubMed] [Google Scholar]
  19. Spadari S., Maga G., Focher F., Ciarrocchi G., Manservigi R., Arcamone F., Capobianco M., Carcuro A., Colonna F., Iotti S. L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J Med Chem. 1992 Oct 30;35(22):4214–4220. doi: 10.1021/jm00100a029. [DOI] [PubMed] [Google Scholar]
  20. Spadari S., Maga G., Verri A., Focher F. Molecular basis for the antiviral and anticancer activities of unnatural L-beta-nucleosides. Expert Opin Investig Drugs. 1998 Aug;7(8):1285–1300. doi: 10.1517/13543784.7.8.1285. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES